Literature DB >> 20101217

Plakoglobin interacts with and increases the protein levels of metastasis suppressor Nm23-H2 and regulates the expression of Nm23-H1.

Z Aktary1, K Chapman, L Lam, A Lo, C Ji, K Graham, L Cook, L Li, J R Mackey, M Pasdar.   

Abstract

Plakoglobin (gamma-catenin) is a homolog of beta-catenin with similar dual adhesive and signaling functions. The adhesive function of these proteins is mediated by their interactions with cadherins, whereas their signaling activity is regulated by association with various intracellular partners. In this respect, beta-catenin has a well-defined oncogenic activity through its role in the Wnt signaling pathway, whereas plakoglobin acts as a tumor/metastasis suppressor through mechanisms that remain unclear. We previously expressed plakoglobin in SCC9 squamous carcinoma cells (SCC9-P) and observed a mesenchymal-to-epidermoid transition. Comparison of the protein and RNA profiles of parental SCC9 cells and SCC9-P transfectants identified various differentially expressed proteins and transcripts, including the nonmetastatic protein 23 (Nm23). In this study, we show that Nm23-H1 mRNA and Nm23-H2 protein are increased after plakoglobin expression. Coimmunoprecipitation and confocal microscopy studies using SCC9-P and various epithelial cell lines with endogenous plakoglobin expression revealed that Nm23 interacts with plakoglobin, cadherins and alpha-catenin. Furthermore, Nm23-H2 is the primary isoform involved in these interactions, which occur prominently in the cytoskeleton-associated pool of cellular proteins. In addition, we show that plakoglobin-Nm23 interaction requires the N-terminal (alpha-catenin interacting) domain of plakoglobin. Our data suggest that by increasing the expression and stability of Nm23, plakoglobin has a role in regulating the metastasis suppressor activity of Nm23, which may further provide a potential mechanism for the tumor/metastasis suppressor function of plakoglobin itself.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20101217     DOI: 10.1038/onc.2009.495

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  33 in total

Review 1.  Janus-faces of NME-oncoprotein interactions.

Authors:  Nikolina Vlatković; Shie-Hong Chang; Mark T Boyd
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-11-01       Impact factor: 3.000

2.  Plakoglobin regulates cell motility through Rho- and fibronectin-dependent Src signaling.

Authors:  Viktor Todorović; Bhushan V Desai; Melanie J Schroeder Patterson; Evangeline V Amargo; Adi D Dubash; Taofei Yin; Jonathan C R Jones; Kathleen J Green
Journal:  J Cell Sci       Date:  2010-09-28       Impact factor: 5.285

Review 3.  Protein-protein interactions: a mechanism regulating the anti-metastatic properties of Nm23-H1.

Authors:  Natascia Marino; Jean-Claude Marshall; Patricia S Steeg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-06-29       Impact factor: 3.000

Review 4.  Learning about the functions of NME/NM23: lessons from knockout mice to silencing strategies.

Authors:  Mathieu Boissan; Marie-Lise Lacombe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-12       Impact factor: 3.000

5.  Plakophilin-2 and the migration, differentiation and transformation of cells derived from the epicardium of neonatal rat hearts.

Authors:  Stephanie A Matthes; Steven Taffet; Mario Delmar
Journal:  Cell Commun Adhes       Date:  2011-10-10

6.  The NDPK/NME superfamily: state of the art.

Authors:  Mathieu Boissan; Uwe Schlattner; Marie-Lise Lacombe
Journal:  Lab Invest       Date:  2018-02       Impact factor: 5.662

7.  Increased expression of plakoglobin is associated with upregulated MAPK and PI3K/AKT signalling pathways in early resectable pancreatic ductal adenocarcinoma.

Authors:  Ekene Nweke; Monde Ntwasa; Martin Brand; John Devar; Martin Smith; Geoffrey Candy
Journal:  Oncol Lett       Date:  2020-03-23       Impact factor: 2.967

Review 8.  Insights into the biology and prevention of tumor metastasis provided by the Nm23 metastasis suppressor gene.

Authors:  Natascia Marino; Joji Nakayama; Joshua W Collins; Patricia S Steeg
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

Review 9.  Modulation of cytoskeletal dynamics by mammalian nucleoside diphosphate kinase (NDPK) proteins.

Authors:  Natasha T Snider; Peter J Altshuler; M Bishr Omary
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-09-20       Impact factor: 3.000

10.  Mechanisms of non-metastatic 2 (NME2)-mediated control of metastasis across tumor types.

Authors:  Ram Krishna Thakur; Vinod Kumar Yadav; Pankaj Kumar; Shantanu Chowdhury
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-10       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.